Mark Cushman Selected Research

Mark Cushman Research Topics

Disease

44	Neoplasms (Cancer) 12/2021 - 01/2002
12	Breast Neoplasms (Breast Cancer) 11/2016 - 03/2004
9	Poisoning 05/2020 - 02/2005
7	Tuberculosis (Tuberculoses) 05/2010 - 03/2005
6	Infections 04/2015 - 08/2008
5	Leukemia 01/2018 - 01/2007
5	Acquired Immunodeficiency Syndrome (AIDS) 04/2008 - 04/2006
3	HIV Infections (HIV Infection) 04/2008 - 09/2005
2	Visceral Leishmaniasis (Kala Azar) 12/2019 - 10/2012
2	Leishmaniasis 11/2019 - 10/2012
2	Carcinoma (Carcinomatosis) 01/2018 - 01/2007
2	Carcinogenesis 01/2012 - 11/2008
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Rheumatoid Arthritis 12/2018
1	African Trypanosomiasis (Nagana) 11/2018
1	Angelman Syndrome (Syndrome, Angelman) 01/2018
1	Neurodevelopmental Disorders 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Glioma (Gliomas) 09/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2015
1	Shock 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 04/2015
1	Wound Infection (Wound Infections) 01/2015
1	Wounds and Injuries (Trauma) 01/2015

Drug/Important Bio-Agent (IBA)

11	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021 - 01/2002
10	Biological ProductsIBA 12/2021 - 11/2004
8	Topoisomerase I InhibitorsIBA 01/2018 - 12/2003
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2005
6	EnzymesIBA 01/2017 - 11/2004
6	Aromatase (CYP19)IBA 01/2016 - 07/2010
6	6,7-dimethyl-8-ribityllumazine synthase (lumazine synthase)IBA 05/2010 - 03/2005
6	CamptothecinIBA 08/2008 - 12/2003
6	NucleosidesIBA 04/2008 - 09/2005
5	Pharmaceutical PreparationsIBA 12/2021 - 11/2003
5	Estrogen ReceptorsIBA 12/2021 - 03/2004
5	Proteins (Proteins, Gene)FDA Link 05/2020 - 02/2005
5	Aromatase InhibitorsIBA 11/2016 - 06/2007
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2012
4	TubulinIBA 10/2004 - 10/2002
3	PoisonsIBA 12/2019 - 12/2012
3	LactamsIBA 01/2017 - 05/2007
3	Selective Estrogen Receptor Modulators (SERM)IBA 11/2016 - 03/2015
3	ResveratrolIBA 09/2015 - 03/2004
3	Antineoplastic Agents (Antineoplastics)IBA 03/2015 - 07/2003
3	NSC 724998IBA 12/2012 - 11/2007
3	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2012 - 04/2011
3	isoquinolineIBA 06/2012 - 07/2005
3	Reverse Transcriptase InhibitorsIBA 04/2008 - 04/2006
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2007 - 11/2003
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2021 - 02/2008
2	indimitecanIBA 01/2018 - 12/2012
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2018 - 01/2018
2	tyrosyl-DNA phosphodiesteraseIBA 01/2017 - 05/2014
2	Tamoxifen FDA LinkGeneric 01/2016 - 05/2012
2	Estrogens (Estrogen)FDA Link 01/2016 - 03/2004
2	ProdrugsIBA 01/2016 - 06/2005
2	Acetates (Acetic Acid Esters)FDA Link 09/2015 - 11/2008
2	3- amino- 6- (3- aminopropyl)- 5,6- dihydro- 5,11- dioxo- 11H- indeno(1,2- c)isoquinolineIBA 03/2012 - 04/2011
2	Riboflavin SynthaseIBA 08/2009 - 09/2007
2	zapotinIBA 11/2008 - 01/2007
2	Antiviral Agents (Antivirals)IBA 08/2008 - 04/2008
2	Human immunodeficiency virus 1 reverse transcriptaseIBA 02/2008 - 09/2005
2	6- (3- (2- hydroxyethyl)amino- 1- propyl)- 5,6- dihydro- 2,3- dimethoxy- 8,9- methylenedioxy- 5,11- dioxo- 11H- indeno(1,2- )isoquinolineIBA 02/2005 - 11/2003
2	2-MethoxyestradiolIBA 10/2004 - 10/2002
2	lavendustin AIBA 04/2003 - 10/2002
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2021
1	Gatifloxacin (Zymar)FDA Link 05/2020
1	MacrolidesIBA 05/2020
1	FluoroquinolonesIBA 05/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2020
1	tofacitinibIBA 12/2018
1	Antiparasitic Agents (Antiparasitics)IBA 11/2018
1	Therapeutic UsesIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	triphenylethyleneIBA 01/2016
1	NitrogenIBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	SurvivinIBA 09/2015
1	Epidermal Growth Factor (EGF)IBA 09/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2015
1	Serine (L-Serine)FDA Link 09/2015
1	Tyrosine (L-Tyrosine)FDA Link 09/2015
1	Cyclin D1IBA 09/2015
1	CaspasesIBA 09/2015
1	Cyclin B1IBA 09/2015
1	ChlorineIBA 05/2015
1	FluorineIBA 05/2015
1	AntigensIBA 04/2015
1	ThiazolesIBA 01/2015
1	Mupirocin (Bactroban)FDA LinkGeneric 01/2015
1	Methicillin (Metin)FDA Link 02/2014
1	7-azaindenoisoquinolineIBA 02/2014
1	Hormones (Hormone)IBA 09/2013
1	N,N-didesmethyl-4-hydroxytamoxifenIBA 06/2013

Therapy/Procedure

6	Chemoprevention 06/2012 - 06/2007
4	Drug Therapy (Chemotherapy) 12/2021 - 06/2008
4	Therapeutics 11/2018 - 09/2005